Gene · 5987
Papers2,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. | Int J Biol Sci | 2022 | 36263177 | PubTator, text mining | PubMed |
| TRIM family contribute to tumorigenesis, cancer development, and drug resistance. | Exp Hematol Oncol | 2022 | 36261847 | PubTator, text mining | PubMed |
| Arabidopsis ORP2A mediates ER-autophagosomal membrane contact sites and regulates PI3P in plant autophagy. | Proc Natl Acad Sci U S A | 2022 | 36252028 | PubTator, text mining | PubMed |
| The roles and targeting options of TRIM family proteins in tumor. | Front Pharmacol | 2022 | 36249749 | PubTator, text mining | PubMed |
| Autophagy Regulates Osteogenic Differentiation of Human Periodontal Ligament Stem Cells Induced by Orthodontic Tension. | Stem Cells Int | 2022 | 36248255 | PubTator, text mining | PubMed |
Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment. | Mol Ther Oncolytics | 2022 | 36247810 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
| Hemipiperazines as peptide-derived molecular photoswitches with low-nanomolar cytotoxicity. | Nat Commun | 2022 | 36241620 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis. | Int J Mol Sci | 2022 | 36232761 | PubTator, text mining | PubMed |
| Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19. | Int J Mol Sci | 2022 | 36232549 | PubTator, text mining | PubMed |
| MEG3 Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer. | Cells | 2022 | 36231143 | PubTator, text mining | PubMed |
| K63 Ubiquitination of P21 Can Facilitate Pellino-1 in the Context of Chronic Obstructive Pulmonary Disease and Lung Cellular Senescence. | Cells | 2022 | 36231077 | PubTator, text mining | PubMed |
| A Ca2+-Mediated Switch of Epiplakin from a Diffuse to Keratin-Bound State Affects Keratin Dynamics. | Cells | 2022 | 36231039 | PubTator, text mining | PubMed |
| [Salivary gland tumors-an overview : Advances in molecular characterization: Part I]. | Pathologie (Heidelb) | 2022 | 36227346 | PubTator, text mining | PubMed |
| Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma. | Int J Immunopathol Pharmacol | 2022 | 36217828 | PubTator, text mining | PubMed |
| HIF1α Promotes BMP9-Mediated Osteoblastic Differentiation and Vascularization by Interacting with CBFA1. | Biomed Res Int | 2022 | 36217388 | PubTator, text mining | PubMed |
| Emerging roles of TRIM27 in cancer and other human diseases. | Front Cell Dev Biol | 2022 | 36200036 | PubTator, text mining | PubMed |
| Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model. | BMB Rep | 2022 | 36195571 | PubTator, text mining | PubMed |
| Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer. | Evid Based Complement Alternat Med | 2022 | 36193130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5987/papers?page=18